Adjuvant chemotherapy for gastric cancer: current evidence and future challenges. - Wikidata - awgldk - TriplyDB

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

http://www.wikidata.org/entity/Q37724644

about

Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis Trends and predictions for gastric cancer mortality in Brazil Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer.Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study.

P2860

Q36303653-BD69B318-4239-4CCF-B3C8-65D38FCDC490 Q36631514-FC512A1B-0861-4155-89A0-DB2452F6CAFE Q36837966-2C4A78A2-A663-46AB-BF03-F194519CB37D Q37141621-20C19E66-28EA-4818-BBC6-3A1D3C4BA22A Q38767113-791E00C3-2E68-42BF-99DC-58FFD6D92AB1 Q53550064-5EAF9438-7CD1-4A94-84E3-CB744EDB4618 Q55007776-6CC5342C-635C-4020-A298-4F10E558EFEF

P2860

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

http://www.wikidata.org/entity/Q37724644

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

@en

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

@nl

type

label

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

@en

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

@nl

prefLabel

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

@en

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

@nl

P1433

Q37724644-7E290003-2302-4F9F-8A23-052A40DB27DC

P1476

Q37724644-91222E45-C45E-43F2-95A2-ED22784D4BDF

P2093

Q37724644-22AAEED4-A874-4CEA-9AE0-654ABCE1116E

Q37724644-96E66672-AC15-4913-A784-5D1C6743BAD3

P2860

Q37724644-021C8C7E-E4F5-40B7-895A-B4D515BD18FA

Q37724644-03C23B84-077E-41B0-BDA6-9D23B5839270

Q37724644-046EABEC-6A0C-4558-9540-52E049DFC25A

Q37724644-0B1118D0-87FB-4B71-8FD0-691F8F869253

Q37724644-120DC078-B4A7-4400-9D15-442635BE64E3

Q37724644-193A64AE-4ACF-4AD8-93D0-727BCBD53B07

Q37724644-1A69ECC4-CF15-4976-9C15-0A8679450C83

Q37724644-1C072CBC-048C-4843-ACB7-4CC795B3B58F

Q37724644-22614E3D-AACA-4307-95C3-C937990580AA

Q37724644-28EAC7BF-FD92-4F7F-A346-19E0DBA5BC4E

P304

Q37724644-5131C2CA-FF06-404C-9D1A-4E29A09FB28F

P31

Q37724644-82B0C217-066D-4FE6-B6C7-F55F768A6F61

P356

Q37724644-887E0CAF-01F0-43AA-ACFF-25F0C7C76D80

P407

Q37724644-9BF58DBD-99D9-45CF-91C4-7C352FFD27DD

P433

Q37724644-32250319-B683-4A0A-ADF2-297C50FE9791

P478

Q37724644-118361D7-B4F0-4FF5-B3F5-ACA775DFB896

P50

Q37724644-47604ABB-A585-4C4F-801D-10A88A9726C5

Q37724644-BE7CC73F-0C85-4153-8BD7-9BE6FCE5C090

Q37724644-F153F283-537D-4D62-AA4B-620618F53091

P577

Q37724644-5D28F76F-3AD5-4D11-BC76-054B00BC83F3

P5875

Q37724644-F9D0B532-4F1F-43A3-BA38-9B00EF964BB5

P698

Q37724644-CDA58EAB-6E01-4245-836F-5384E621144F

P921

Q37724644-0996BE31-D448-4043-9F9F-6DCF3F43F443

P932

Q37724644-2AA4290F-83B7-42FF-97C4-D0987E534F5F

P356

WJG.V20.I16.4516

P1433

World Journal of Gastroenterology

P1476

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges

@en

P2093

Giacomo Bregni

http://www.w3.org/2001/XMLSchema#string

Gianluca Tomasello

http://www.w3.org/2001/XMLSchema#string

P2860

Post-surgical chemotherapy versus surgery alone for resectable gastric cancer

Bias in published cost effectiveness studies: systematic review.

The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after fir

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

P304

4516-4525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I16.4516

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Filippo Pietrantonio

Maria Di Bartolomeo

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261999088

http://www.w3.org/2001/XMLSchema#string

P698

24782604

http://www.w3.org/2001/XMLSchema#string

P921

P932

4000488

http://www.w3.org/2001/XMLSchema#string